story of the week
Ipatasertib Plus Paclitaxel for PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ipatasertib plus Paclitaxel for patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial
Clin. Cancer Res 2024 Jul 26;[EPub Ahead of Print], RA Dent, SB Kim, M Oliveira, C Barrios, J O'Shaughnessy, SJ Isakoff, S Saji, R Freitas-Junior, M Philco, I Bondarenko, Q Lian, D Bradley, H Hinton, MJ Wongchenko, SJ Reilly, N TurnerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.